Next report date
Report period
H2 2024
EPS estimate
−0.11USD
Revenue estimate
128.97 MUSD
−210.74 MUSD
122.27 MUSD
61.54 M
Om MAYNE PHARMA GROUP LIMITED
Sektor
Bransch
VD
Shawn Patrick O'Brien
Webbplats
Huvudkvarter
Salisbury
Grundat
2005
ISIN
AU000000MYX0
FIGI
BBG0046WCK79
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
